| Literature DB >> 35383267 |
Arisa Kita1, Yuki Saito2, Norihiro Miura3, Maki Miyajima3, Sena Yamamoto3, Tsukasa Sato3, Takatoshi Yotsuyanagi1, Mineko Fujimiya4, Takako S Chikenji5,6.
Abstract
Pathologic diabetic wound healing is caused by sequential and progressive deterioration of hemostasis, inflammation, proliferation, and resolution/remodeling. Cellular senescence promotes wound healing; however, diabetic wounds exhibit low levels of senescent factors and accumulate senescent cells, which impair the healing process. Here we show that the number of p15INK4B + PDGFRα + senescent mesenchymal cells in adipose tissue increases transiently during early phases of wound healing in both non-diabetic mice and humans. Transplantation of adipose tissue from diabetic mice into non-diabetic mice results in impaired wound healing and an altered cellular senescence-associated secretory phenotype (SASP), suggesting that insufficient induction of adipose tissue senescence after injury is a pathological mechanism of diabetic wound healing. These results provide insight into how regulation of senescence in adipose tissue contributes to wound healing and could constitute a basis for developing therapeutic treatment for wound healing impairment in diabetes.Entities:
Mesh:
Year: 2022 PMID: 35383267 PMCID: PMC8983691 DOI: 10.1038/s42003-022-03266-3
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642
Fig. 1Lepr mice exhibit impaired wound healing.
a Body weight and blood glucose levels for Lepr and Lper mice before full-thickness excisional skin wounds were created (n = 12 for Lepr and n = 14 for Lper mice). b Representative wound images during the healing process and (c) the wound area, reported as the percent of wound closure compared to the 0 days post wound (0 DPW) area (n = 12 for Lepr 0 and 2 DPW, n = 6 for Lepr 5 and 8 DPW, n = 14 for Lper 0 and 2 DPW, and n = 7 for Lepr 5 and 8 DPW). d Representative images of H&E staining and Masson trichrome (MT) staining of a wound at pre-wounding, 2 DPW, and 8 DPW. e Quantitative data concerning the number of infiltrated cells. f Area covered by collagen deposits. g Area covered by adipose tissue (n = 3 for each group). h–j Representative images of a wound at 8 DPW following immunostaining for PDGFRα and α-SMA (h), and percentage of cells positive for either PDGFRα, α-SMA, or both in interstitial connective tissue (i) and in granulation tissue (j) (n = 3 for each group). Quantitative data are shown as means ± SE in dot plots or box-and-whisker plots with IQRs and 1.5 times the IQR. p-values were determined using either a two-tailed Student’s t-test or the Tukey method for one-way ANOVA (*p < 0.05 and **p < 0.001).
Fig. 2Transplantation of adipose tissue derived from Lepr mice into Leprmice impairs wound healing.
a Schematic diagram of the procedure for the adipose tissue transplantation (ATT) experiments. b Representative image of H&E staining and MT staining of a wound at 8 DPW and (c) the quantitative analysis of the wound healing histological score (n = 8 in the ATT group and n = 4 in the sham group). d, e Representative images of PDGFRα and α-SMA immunostaining of a wound edge at 8 DPW and quantitative data on the percentage of PDGFRα and α-SMA + cells in interstitial connective tissue (n = 4 for each group). f Relative levels of Acta2 and Pdgfra mRNA in Lepr and Lepr mouse skin at 8 DPW. g, h Localization of CM-DiI–labeled adipose tissue–derived cells within wound regions and quantitative data (n = 3 for each group). Quantitative data are shown as means ± SE in either dot plots or box-and-whisker plots with IQRs and 1.5 times the IQR. p-values were determined using a two-tailed Student’s t-test or the Tukey method for one-way ANOVA (*p < 0.05 and **p < 0.001).
Fig. 3Cellular senescence in subcutaneous adipose tissue during wound healing in Lepr and Lepr mice.
a Relative mRNA expression of senescence-related genes at pre-wound, 2 DPW, and 8 DPW in Lepr and Lepr mice (n = 7 for each group). b, c Principal component analysis (PCA) of the levels of senescence based on senescence-related gene expression at pre-wound, 2 DPW, and 8 DPW for Lepr and Lepr mice in skin and adipose tissue. Quantitative data are presented as means and medians with IQRs and 1.5 times the IQR and are shown as box-and-whisker plots. p-values were determined using the Tukey method for one-way ANOVA (*p < 0.05).
Fig. 4p15INK4B expression in PDGFRα + cells in subcutaneous adipose tissue during wound healing in Lepr and Lepr mice.
a Representative images of adipose tissue following immunostaining for PDGFRα and p15INK4B. Samples were collected at pre-wounding, 2 DPW, and 8 DPW. b, c Percentage of PDGFRα + cells (Leprpre-wounding: n = 3; Lepr 2 DPW: n = 4; Lepr 8 DPW; n = 3; Lepr pre-wounding: n = 3; Lepr 2 DPW: n = 3; Lepr 8 DPW; n = 3) and Pdgfra mRNA levels in adipose tissue at pre-wounding, 2 DPW, and 8 DPW (Leprpre-wounding: n = 6; Lepr 2 DPW: n = 7; Lepr 8 DPW; n = 7; Lepr pre-wounding: n = 7; Lepr 2 DPW: n = 7; Lepr 8 DPW; n = 6). d, e Percentage of PDGFRα − and p15INK4B + cells and fluorescence intensity of p15INK4B in PDGFRα + cells (Leprpre-wounding: n = 3; Lepr 2 DPW: n = 4; Lepr 8 DPW; n = 3; Lepr pre-wounding: n = 3; Lepr 2 DPW: n = 3; Lepr 8 DPW; n = 3). Quantitative data are presented as box-and-whisker plots with IQRs and 1.5 times the IQR. p-values were determined using the Tukey method for one-way ANOVA (*p < 0.05 and **p < 0.001).
Information of patients with diabetes and controls.
| Donor/Group | Sex | Age | DM Daignosis | HbA1c (NGSP) [%] | Diagnosis | Wound (Source of the adipose tissue) | Time post-wounding | Comorbidity | Past Medical History(PMH) | Medication |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-DM1 | Male | 65 | - | - | Electric injury, Burn | Abdomen | 19 | No | Postoperative hepatoma | Celecoxib, rebamipide |
| Non-DM2 | Male | 82 | - | - | Burn | Thigh | 39 | Chronic renal impairment, dementia | Myocardial infarction, cerebral infarction, postoperative colorectal cancer | Esomeprazole magnesium hydrate, acetaminophen, aspirin, carvedilol, amlodipine besilate, amiodarone hydrochloride, silodosin |
| Non-DM3 | Male | 65 | - | - | Burn | Lower leg | 39 | Hypertension, hypercholesterolemia, narcolepsy | - | Esomeprazole magnesium hydrate, loxoprofen sodium hydrate, amoxicillin hydrate, aspirin, carvedilol, clopidogrel sulfate, vitamin B6, vitamin B12 |
| Non-DM4 | Male | 45 | - | - | Burn | Hip | 39 | Smoke inhalation | Traumatic intracranial hemorrhage | Lactulose, meropenem |
| Non-DM5 | Female | 70 | - | - | Pressure ulcer | Chest | 70 | Chronic obstructive pulmonary disease(COPD) | Breast cancer | Fluticasone furoate, umeclidinium bromide vilanterol trifenatate, cilnidipine, allopurinol, sodium risedronate hydrate, rabeprazole sodium, domperidone, syakuyaku-kanzo-to(kampo medicine) |
| Non-DM6 | Male | 21 | - | - | Pressure ulcer | Ischial region | 84 | Spinal cord injury(Paraplegia) | - | - |
| DM1 | Female | 76 | + | 7.1 | Chronic traumatic ulcer | Elbow | 11 | Thrombocytopenic purpura, atrial fibrillation, iron deficiency anemia, dementia, gastric cancer | Thoracic compression fracture | Denosumab, prednisolone (15 mg/day), fenofibrate, pilsicainide hydrochloride hydrate, vonoprazan fumarate, clotiazepam, solifenacin succinate, sodium ferrous citrate, donepezil hydrochloride, magnesium oxide |
| DM2 | Male | 64 | + | 7.3 | Burn | Thigh | 13 | Hypertension | unknown | Rikkunshito (kampo medicine), omeprazole |
| DM3 | Male | 60 | + | 5.2 | Burn | Back | 17 | Multi-hepatoma, liver cirrhosis, esophageal varices, hypertension | - | Rikkunshito (kampo medicine), insulin human (genetical recombination), micafungin sodium, ceftazidime hydrate, linezolid, lactulose |
| DM4* | Male | 60 | + | 5.2 | Burn | Abdomen | 31 | Multi-hepatoma, liver cirrhosis, esophageal varices, hypertension | - | Acetaminophen, rikkunshito (kampo medicine), insulin human (genetical recombination), furosemide, ceftazidime hydrate, linezolid, lactulose, entecavir hydrate |
| DM5 | Male | 70 | + | 11 | Fournier gangrene | Hip | 35 | Hypercholesterolemia | - | Canagliflozin hydrate, metformin hydrochloride, insulin degludec(genetical recombination), olmesartan medoxomil, pitavastatin calcium hydrate |
| DM6 | Female | 82 | + | 6.3 | Ulcer after vein harvesting | Lower leg | 64 | Gallstone, diabetic retinopathy, hypertension, hypercholesteremia | Postoperative abdominal aortic aneurysm, inflammation of mesenteric adipose tissue, ischemic enteritis, cholangitis aneurysm, interstitial lung disease | Acetaminophen, magnesium oxide, vildagliptin, sennoside A·B calcium, insulin lispro(genetical recombination), insulin glargine(genetical recombination), pilsicainide hydrochloride hydrate, aspirin, warfarin potassium, bisoprolol fumarate, vonoprazan fumarate, atorvastatin calcium hydrate |
*Same patient as DM3
Fig. 5Cellular senescence in subcutaneous adipose tissue during wound healing in diabetic patients.
a, b Representative images of adipose tissue immunostained for PDGFRα, p15INK4B, and γH2A.X. during wound healing in diabetic and non-diabetic patients. c, d Correlation between the percentage of p15INK4B + or γH2A.X + cells in PDGFRα + cells and time post-wounding (n = 6 for each group). Correlations were examined statistically using Pearson’s correlation coefficient, and 95% confidence intervals are shown with translucent fill corresponding to each marker color.
Fig. 6Components of post-wound adipose tissue-derived cytokines in Leprand Lepr mice and their effect on cell migration.
a Proteome profiler antibody array analysis of SASP-containing culture media (CM) collected from the organ culture of adipose tissue at pre-wounding, 2 DPW, and 8 DPW. b Hierarchical clustering of differentially expressed cytokine expression. Cytokines with higher expression are depicted in red, cytokines with lower expression are depicted in blue, and cytokines with no difference are depicted in white. c Representative phase-contrast image of wound assay treated with adipose tissue-derived cultured media collected from either Lepr or Lepr mice at 2DPW and (d) the percentage of wound closure at each time point, from immediately after wounding (D0) to 4 d after wounding (D4) (Ctrl DMEM: n = 15; Lepr CM: n = 12; Lepr CM: n = 15). Quantitative data are shown as box-and-whisker plots with IQRs and 1.5 times the IQR. p-values were determined using the Tukey method for one-way ANOVA (*p < 0.05 and **p < 0.001).
Fig. 7Schematic illustration of the contributions of senescent cells in adipose tissue during physiological and diabetic wound healing.
Transient mesenchymal cell senescence occurs in adipose tissue in physiological wound healing after injury; however, accumulation of cell senescence occurs concurrently with expression of different components of SASP in diabetic wound healing. Our data suggest that impairment of senescence in adipose tissue contributes to intractable wound healing in diabetes.